Re:Moderna Covid vaccine candidate almost 95% effective, tri...
by tooltalk on Monday November 16, 2020 @11:41AM
(#25113737)
Reading your source, it seems the bureaucratic limitation was their #1; then comes politics.
"Pfizer declined the R&D funding in order to "liberate" scientists from bureaucratic limitations as they worked to develop a COVID-19 vaccine, the pharmaceutical company's CEO, Dr. Albert Bourla, said in a September interview with CBS News' Margaret Brennan."
"Pfizer declined the R&D funding in order to "liberate" scientists from bureaucratic limitations as they worked to develop a COVID-19 vaccine, the pharmaceutical company's CEO, Dr. Albert Bourla, said in a September interview with CBS News' Margaret Brennan."